Literature DB >> 15447976

L1CAM, INP10, P-cadherin, tPA and ITGB4 over-expression in malignant pleural mesotheliomas revealed by combined use of cDNA and tissue microarray.

E Kettunen1, A G Nicholson, B Nagy, H Wikman, J K Seppänen, T Stjernvall, T Ollikainen, V Kinnula, S Nordling, J Hollmén, S Anttila, S Knuutila.   

Abstract

Malignant pleural mesothelioma (MM) is a rare tumour with high mortality, which can exhibit various morphologies classified as epithelioid, biphasic and sarcomatoid subtypes. To investigate the molecular changes in these tumours, we studied gene expression patterns by combined use of cDNA arrays and tumour tissue microarrays (TMA). Deregulation of the expression of 588 cancer-related genes was screened in 16 MM comprising all three subtypes and compared with references, i.e. normal mesothelial cell lines and pleural mesothelium. Array data were analysed using three statistical methods; principal component analysis (PCA), permutation test and receiver operating characteristic (ROC) curves. Eleven genes were verified by real-time RT-PCR. Genes encoding two adhesion molecules [COL1A2 and integrin beta4 (ITGB4)] and a chemokine (INP10) were up-regulated in MM compared with both the cell lines and pleural mesothelium. There was a type-specific up-regulation of semaphorin E, ITGB4 and P-cadherin in epithelioid MM, matrix metalloproteinase 9 (MMP9) and tissue-type plasminogen activator (tPA) in sarcomatoid MM and neural cell adhesion molecule L1 (L1CAM) and INP10 in biphasic MM. Immunohistochemistry on TMA containing 47 MM (26 epithelioid, 15 sarcomatoid and six biphasic) was performed for five proteins, ITGB4, P-cadherin, tPA, INP10 and L1CAM. INP10 expression was increased in MM in general compared with normal mesothelium, while increased expression of P-cadherin, L1CAM and ITGB4 was more specific in MMs exhibiting an epithelioid growth pattern. The over-expression of tPA was more frequent in epithelioid MM despite higher mRNA levels in sarcomatoid and biphasic MM. We conclude that several proteins, associated with cell adhesion either directly (ITGB4, L1CAM, P-cadherin) or as a regulatory factor (INP10), are differentially expressed in MM. In particular, INP10, ITGB4 and COL1A2 were up-regulated in MM compared with both reference sample types, suggesting a relationship with development of these tumours.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15447976     DOI: 10.1093/carcin/bgh276

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  12 in total

1.  Hunting for a pleural fluid test for mesothelioma: is soluble mesothelin the answer?

Authors:  Y C Gary Lee
Journal:  Thorax       Date:  2007-07       Impact factor: 9.139

2.  Analysis of differentially expressed genes, clinical value and biological pathways in prostate cancer.

Authors:  Zhaohui He; Fucai Tang; Zechao Lu; Yucong Huang; Hanqi Lei; Zhibiao Li; Guohua Zeng
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

3.  L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma.

Authors:  Jussuf T Kaifi; Ulrich Zinnkann; Emre F Yekebas; Paulus G Schurr; Uta Reichelt; Robin Wachowiak; Henning C Fiegel; Susann Petri; Melitta Schachner; Jakob R Izbicki
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

4.  Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype.

Authors:  Oluf Dimitri Røe; Endre Anderssen; Eli Helge; Caroline Hild Pettersen; Karina Standahl Olsen; Helmut Sandeck; Rune Haaverstad; Steinar Lundgren; Erik Larsson
Journal:  PLoS One       Date:  2009-08-07       Impact factor: 3.240

5.  Overexpression of CD24, c-myc and phospholipase 2A in prostate cancer tissue samples obtained by needle biopsy.

Authors:  Balint Nagy; Attila Szendroi; Imre Romics
Journal:  Pathol Oncol Res       Date:  2008-08-28       Impact factor: 3.201

6.  Gene expression profiles in asbestos-exposed epithelial and mesothelial lung cell lines.

Authors:  Penny Nymark; Pamela M Lindholm; Mikko V Korpela; Leo Lahti; Salla Ruosaari; Samuel Kaski; Jaakko Hollmén; Sisko Anttila; Vuokko L Kinnula; Sakari Knuutila
Journal:  BMC Genomics       Date:  2007-03-01       Impact factor: 3.969

7.  Expression of cancer-associated molecules in malignant mesothelioma.

Authors:  Ben Davidson
Journal:  Biomark Insights       Date:  2007-05-30

8.  Targeting L1 cell adhesion molecule expression using liposome-encapsulated siRNA suppresses prostate cancer bone metastasis and growth.

Authors:  Shian-Ying Sung; I-Hui Wu; Pei-Hsin Chuang; John A Petros; Hsi-Chin Wu; Hong-Jie Zeng; Wei-Chien Huang; Leland W K Chung; Chia-Ling Hsieh
Journal:  Oncotarget       Date:  2014-10-30

9.  Spatial and molecular resolution of diffuse malignant mesothelioma heterogeneity by integrating label-free FTIR imaging, laser capture microdissection and proteomics.

Authors:  Frederik Großerueschkamp; Thilo Bracht; Hanna C Diehl; Claus Kuepper; Maike Ahrens; Angela Kallenbach-Thieltges; Axel Mosig; Martin Eisenacher; Katrin Marcus; Thomas Behrens; Thomas Brüning; Dirk Theegarten; Barbara Sitek; Klaus Gerwert
Journal:  Sci Rep       Date:  2017-03-30       Impact factor: 4.379

10.  Embryonic mesothelial-derived hepatic lineage of quiescent and heterogenous scar-orchestrating cells defined but suppressed by WT1.

Authors:  Timothy James Kendall; Catherine Mary Duff; Luke Boulter; David H Wilson; Elisabeth Freyer; Stuart Aitken; Stuart John Forbes; John Peter Iredale; Nicholas Dixon Hastie
Journal:  Nat Commun       Date:  2019-10-15       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.